Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ChatGPT picks 2 dividends to buy in 2026

ChatGPT picks 2 dividends to buy in 2026
Paul L.
Stocks

Dividend investing remains a core strategy for market participants seeking steady income and long-term capital appreciation in 2026.

With interest rates stabilizing and equity markets navigating a mixed economic backdrop, investors looking for opportunities can focus on companies that combine reliable cash flow, sustainable payout ratios, and strong competitive positioning.

To this end, as 2026 unfolds, Finbold turned to OpenAI’s ChatGPT to identify two dividend stocks worth considering.

Merck & Co (NYSE: MRK)

Merck (NYSE: MRK) enters 2026 as one of the more defensively positioned dividend names in the healthcare space. As of press time, the stock was trading at $121 and offers a forward dividend of $3.40 per share, translating to a yield of 2.80%.

The company maintains a forward payout ratio of 34.93%, a level that signals strong dividend coverage and leaves meaningful room for reinvestment and future increases.

MRK stock price and dividend details. Source: Dividend.com

The pharmaceutical giant has raised its dividend for 15 consecutive years, highlighting its long-standing commitment to shareholder returns. 

Its quarterly dividend currently stands at $0.85, with the next payment scheduled for early April 2026. 

Fundamentally, Merck benefits from the resilience of the healthcare sector, where demand tends to remain stable even during economic slowdowns.

At the same time, its oncology franchise, led by blockbuster treatments such as Keytruda, continues to anchor revenue generation, while the broader drug pipeline provides potential for future growth.

ConocoPhillips (NYSE: COP)

The second pick by the AI model shifts the focus from defensive healthcare to the cyclical dynamics of the energy market with ConocoPhillips (NYSE: COP), a major independent exploration and production company.

Unlike more defensive dividend plays, ConocoPhillips offers investors direct exposure to global oil and gas prices, which can amplify both risks and rewards. 

The company has structured its capital strategy around disciplined spending and strong free cash flow generation, a model designed to sustain shareholder returns even when commodity markets fluctuate. 

By tying dividends and buybacks closely to cash flow performance, management reinforces the durability of its payout policy across different energy price cycles.

As of the close of the last Friday session, COP was trading at $111.43. The stock carries a forward annual dividend of $3.36 per share, translating to a yield of 3.02%. Its forward payout ratio stands at 50.06%, a moderate level for an energy producer that reflects a balance between reinvestment in production assets and returning capital to shareholders.

COP stock price and dividend details. Source: Dividend.com

The company distributes dividends on a quarterly basis, with the next payment of $0.84 scheduled for March 2026. 

Featured image via Shutterstock




Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users worldwide
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD
Finbold Career

Join Finbold's newsroom, become a crypto reporter today!

Apply now to join Finbold as a crypto/finance news writer!

Latest posts

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Stocks

Finbold AI Agent

How AI Price Predictions Work

We use cutting-edge AI models to forecast future prices for stocks and crypto.

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.